Clot-Fighting Drug Plavix Set to Lose Patent Protection

Wednesday, May 16, 2012 - 17:20 in Health & Medicine

The drug, which prevents clots among heart attack patients, will no longer be promoted by Bristol-Myers Squibb because of an influx of cheaper generic alternatives.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net